Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Unknown 4Completed 1

Sponsor Class

OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Thoracic 22Head & Neck 11Gastrointestinal 8CNS 5Breast 5Gynecologic 3Other solid neoplasm 2Tumor-Agnostic 1Sarcoma 1Lymphoid 1Dermatologic 1

Conditions

Breast Neoplasms 4Breast Cancer Organoids 1

Interventions

Cyclophosphamide 423Trastuzumab 414Paclitaxel 375Docetaxel 314Capecitabine 266Letrozole 262Carboplatin 257Doxorubicin 213Tamoxifen 184Fulvestrant 176Epirubicin 176Radiotherapy 171Anastrozole 164pembrolizumab 152pertuzumab 147Surveys and Questionnaires 146Exercise 142exemestane 128Vinorelbine 127palbociclib 124Bevacizumab 123Magnetic Resonance Spectroscopy 120Blood Specimen Collection 120Drug Therapy 106Albumin-Bound Paclitaxel 105Gemcitabine 99130-nm albumin-bound paclitaxel 98pyrotinib 92eribulin 90Biopsy 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Endostatins × Breast × Clear all
NCT03925233 2019-04-24

Breast Cancer Treatment Based on Organ-like Culture

Xijing Hospital

Unknown
300 enrolled
Breast

Breast Cancer Organoids

NCT03907098 2019-04-08

Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast Cancer

Zhejiang Cancer Hospital

Phase 2 Unknown
50 enrolled
Breast

Breast Neoplasms

NCT02489409 2017-07-17

Recombinant Human Endostatin (EndostarTM) Injection in Treatment of Recurrent Metastatic Breast Cancer

Xinjiang Medical University

Phase 2 Unknown
120 enrolled
Breast

Breast Neoplasms

NCT01479036 2011-11-24

CBCRT01

Xijing Hospital

Phase 3 Unknown
800 enrolled
Breast

Breast Neoplasms

NCT00604435 2010-01-20

Neoadjuvant Endostatin and Chemotherapy for Breast Cancer

Xijing Hospital

Phase 2 Completed
69 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡